- Home
- CNTB vs RPTX Comparison
CNTB vs RPTX Comparison
Compare CNTB & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- RPTX
- Stock Information
- Founded
- CNTB 2012
- RPTX 2016
- Country
- CNTB United States
- RPTX Canada
- Employees
- CNTB N/A
- RPTX N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- CNTB Health Care
- RPTX Health Care
- Exchange
- CNTB Nasdaq
- RPTX Nasdaq
- Market Cap
- CNTB 93.9M
- RPTX 92.4M
- IPO Year
- CNTB 2021
- RPTX 2020
- Fundamental
- Price
- CNTB $2.80
- RPTX $2.13
- Analyst Decision
- CNTB Strong Buy
- RPTX Strong Buy
- Analyst Count
- CNTB 3
- RPTX 3
- Target Price
- CNTB $8.33
- RPTX $3.50
- AVG Volume (30 Days)
- CNTB 591.8K
- RPTX 1.1M
- Earning Date
- CNTB 11-12-2025
- RPTX 11-14-2025
- Dividend Yield
- CNTB N/A
- RPTX N/A
- EPS Growth
- CNTB N/A
- RPTX N/A
- EPS
- CNTB N/A
- RPTX N/A
- Revenue
- CNTB $762,000.00
- RPTX $11,870,000.00
- Revenue This Year
- CNTB N/A
- RPTX N/A
- Revenue Next Year
- CNTB $453,067.90
- RPTX N/A
- P/E Ratio
- CNTB N/A
- RPTX N/A
- Revenue Growth
- CNTB N/A
- RPTX N/A
- 52 Week Low
- CNTB $0.51
- RPTX $0.89
- 52 Week High
- CNTB $3.28
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- CNTB 68.76
- RPTX 64.44
- Support Level
- CNTB $1.49
- RPTX $2.08
- Resistance Level
- CNTB $3.28
- RPTX $2.30
- Average True Range (ATR)
- CNTB 0.33
- RPTX 0.08
- MACD
- CNTB 0.12
- RPTX 0.04
- Stochastic Oscillator
- CNTB 73.01
- RPTX 73.08
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.